| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Built on GE HealthCare's 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitor...
GE HealthCare (NASDAQ:GEHC) today announced collaborations with two leading U.S. health systems—The Queen's Health Systems ...
BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $87 to $89.
Barclays analyst Matt Miksic initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight rating and announce...
Citigroup analyst Joanne Wuensch downgrades GE HealthCare Techs (NASDAQ:GEHC) from Buy to Neutral and lowers the price targe...
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...